Canbrs Therapeutics Private Limited
Develops nanotechnology-based cancer therapies for women.
2022 | Chennai, Tamil Nadu (India) | Active
Canbrs Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 11 Months
About Canbrs Therapeutics
Canbrs Therapeutics Private Limited (CTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 23 June 2022 (Two years and 11 months 20 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Balu Ranganathan and Hema Ramadurai serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100TN2022PTC153292
- Company No.
153292
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Life Sciences
Canbrs Therapeutics Private Limited
Explore comprehensive data for Canbrs Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Canbrs Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balu Ranganathan  | Director | 23-Jun-2022 | Current |
| Hema Ramadurai | Director | 23-Jun-2022 | Current |
Financial Performance of Canbrs Therapeutics.
Enhance accessibility to Canbrs Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Canbrs Therapeutics?
Unlock access to Canbrs Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Canbrs Therapeutics?
Canbrs Therapeutics has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Canbrs Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canbrs Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Canbrs Therapeutics
Recent activity within the organization
- Director Appointment
Balu Ranganathan was appointed as a Director was appointed as a Director on 23 Jun 2022 & has been associated with this company since 2 years 11 months .
- Director Appointment
Hema Ramadurai was appointed as a Director was appointed as a Director on 23 Jun 2022 & has been associated with this company since 2 years 11 months .
- Company Incorporation
Canbrs Therapeutics Private Limited was registered on 23 Jun 2022 with Roc Chennai & aged 2 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Canbrs Therapeutics Private Limited?
Canbrs Therapeutics Private Limited was incorporated on 23 Jun 2022.
What is authorized share capital and paid-up capital of Canbrs Therapeutics Private Limited?
The authorized share capital of Canbrs Therapeutics Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Canbrs Therapeutics Private Limited?
Currently 2 directors are associated with Canbrs Therapeutics Private Limited.
- Balu Ranganathan
- Hema Ramadurai
What is the registered address of Canbrs Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Canbrs Therapeutics Private Limited is Iit Madras Research Park No. 1 Fa I Floor Kanagam Road Taramani, Adayar India, Chennai, Tamil Nadu, 600113.
What is the corporate identification number (CIN) and company number of Canbrs Therapeutics Private Limited?
The corporate identification number (CIN) of Canbrs Therapeutics Private Limited is U73100TN2022PTC153292 and the company number is 153292 as per Ministry of Corporate Affairs (MCA).
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records